Entera Bio
ENTX
6 hedge funds and large institutions have $3.49M invested in Entera Bio in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.19% less ownership
Funds ownership: 9.49% → 9.3% (-0.19%)
14% less funds holding
Funds holding: 7 → 6 (-1)
25% less capital invested
Capital invested by funds: $4.67M → $3.49M (-$1.18M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
DLD Asset Management
New York
|
+$145K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$4.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$249K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$388 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $1.47M | – | – | – |
|
|
DAM
2
DLD Asset Management
New York
| $1.27M | +$145K | +37,416 | +11% |
|
|
WCM
3
Wildcat Capital Management
New York
| $697K | – | – | – |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $49K | +$4.13K | +1,063 | +7% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | -$388 | -100 | -10% |
|
|
6
UBS Group
Zurich,
Switzerland
| $2K | -$1.75K | -450 | -40% |
|
|
CBA
7
Coastal Bridge Advisors
Westport,
Connecticut
| – | -$249K | -60,060 | Closed |
|
ENTX Hedge Fund Activity: Q2 2019 in Review
6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2019, worth a combined $3.49M — down 25% from $4.67M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENTX and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was DLD Asset Management, adding an estimated $145K. The largest seller was Coastal Bridge Advisors, exiting entirely with an estimated $249K sold.
- 6 institutional investors held Entera Bio (ENTX) as of Q2 2019, down from 7 in Q1 2019.
- Funds reported $3.49M of Entera Bio stock for Q2 2019, down 25% quarter-over-quarter.
- 0 funds opened new Entera Bio positions in Q2 2019 and 1 closed out, a net change of -1 holder.
- The largest Entera Bio buyer in Q2 2019 was DLD Asset Management, an estimated $145K added.
- The largest Entera Bio seller in Q2 2019 was Coastal Bridge Advisors, an estimated $249K sold.
Based on aggregated 13F filings for Q2 2019.